pancreatitis tirzepatide and Risk: Safety Guide Pancreatitis in Patients Receiving Tirzepatide

Special cells in the skin make melanin

If confirmed, the findings could add to a growing list of GLP-1 side effects that were not originally disclosed on the drug labels

Its dual receptor activity suggests potential advantages in metabolic regulation, but more extensive clinical data are needed to confirm its safety and effectiveness

Due to display and light issues, please refer to the actual product received

Revised: 5/2026 Full Prescribing Information WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures